Details of the Drug
General Information of Drug (ID: DMLIKM1)
| Drug Name |
AC-100
|
||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Synonyms |
Bicyclo[4.2.0]octa-1,3,5-trien-3-ylboronic acid; BENZOCYCLOBUTANE-4-BORONIC ACID; Boronic acid, bicyclo[4.2.0]octa-1,3,5-trien-3-yl-; AC-100; SCHEMBL12759201; KS-00000SRU; MolPort-005-942-889; ZINC196051840; AKOS025146995; DS-8536; BC225113; AK164312; 1,2-Dihydrobenzocyclobutene-4-ylboranic acid; CS-0043999; J3.522.588I; 4-bbcb benzocyclobutene-4-boronic acid
|
||||||||||||||||||||||
| Indication |
|
||||||||||||||||||||||
| Affected Organisms |
Humans and other mammals
|
||||||||||||||||||||||
| Drug Type |
Small molecular drug
|
||||||||||||||||||||||
| Sequence |
>Matrix extracellular phosphoglycoprotein (242-264)
TDLQERGDNDISPFSGDGQPFKD |
||||||||||||||||||||||
| Structure |
![]() |
||||||||||||||||||||||
| 3D MOL | 2D MOL | ||||||||||||||||||||||
| Chemical Identifiers |
|
||||||||||||||||||||||
| Cross-matching ID | |||||||||||||||||||||||

